Genprex Dividend
Dividend criteriumcontroles 0/6
Genprex does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-172.2%
Terugkoop Rendement
Totaal aandeelhoudersrendement | -172.2% |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Can Genprex (NASDAQ:GNPX) Afford To Invest In Growth?
Aug 16Here's Why We're Watching Genprex's (NASDAQ:GNPX) Cash Burn Situation
Jan 31Genprex (NASDAQ:GNPX) Is In A Good Position To Deliver On Growth Plans
Oct 12Genprex stock rises 13% on safety panel nod to continue trial of Reqorsa/Tagrisso combo for lung cancer
Aug 15We're Not Very Worried About Genprex's (NASDAQ:GNPX) Cash Burn Rate
Jun 14Here's Why We're Not Too Worried About Genprex's (NASDAQ:GNPX) Cash Burn Situation
Feb 09Genprex: Limited Clinical Data To Justify Risk
Nov 19We Think Genprex (NASDAQ:GNPX) Can Afford To Drive Business Growth
Oct 27Genprex (NASDAQ:GNPX) Is In A Good Position To Deliver On Growth Plans
Jun 11Genprex receives IRB approval for NSCLC gene therapy trial; shares up 4%
May 05Genprex' stock jumps after corporate update
Feb 01Genprex achieves manufacturing milestone for immunogene therapy for upcoming lung cancer trials
Jan 13Genprex completes manufacturing scale-up of lung cancer therapy
Dec 22Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if GNPX's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if GNPX's dividend payments have been increasing.
Dividendrendement versus markt
Genprex Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (GNPX) | n/a |
Markt onderkant 25% (US) | 1.5% |
Markt Top 25% (US) | 4.5% |
Gemiddelde industrie (Biotechs) | 2.2% |
Analist prognose (GNPX) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate GNPX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate GNPX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate GNPX's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as GNPX has not reported any payouts.